Chin‐Chan Lee
- Nephrology top 1%
- Dialysis and Renal Disease Management 27
- Chronic Kidney Disease and Diabetes 12
- Emergency Medical Services top 5%
- Ophthalmology top 5%
- Retinal Diseases and Treatments 5
- Psychiatry and Mental health top 10%
-
- Retinal Imaging and Analysis 6
-
- Diet and metabolism studies 4
-
- Effects and risks of endocrine disrupting chemicals 4
-
- Restless Legs Syndrome Research 4
-
- COVID-19 Clinical Research Studies 3
- Co-authors
- Chiao‐Yin SunI‐Wen WuHeng-Jung HsuMai-Szu WuChia‐Chi ChouLiang‐Jen WangChun‐Yu ChenHeng‐Chih Pan
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Chin‐Chan Lee
62 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 109
- Nephrology 576
- Emergency Medical Services 86
- Biological Psychiatry 20
- Ophthalmology 72
- Psychiatry and Mental health 113
Countries citing papers authored by Chin‐Chan Lee
This map shows the geographic impact of Chin‐Chan Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin‐Chan Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin‐Chan Lee more than expected).
Fields of papers citing papers by Chin‐Chan Lee
This network shows the impact of papers produced by Chin‐Chan Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin‐Chan Lee. The network helps show where Chin‐Chan Lee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chin‐Chan Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 15 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 18 | |
| 11 | 2020 | 32 | |
| 12 | 2019 | 41 | |
| 13 | 2018 | 18 | |
| 14 | 2018 | 7 | |
| 15 | 2014 | 26 | |
| 16 | 2013 | 8 | |
| 17 | 2012 | 33 | |
| 18 | 2012 | 20 | |
| 19 | 2008 | 71 | |
| 20 | Prognostic Predictor of Acute Paraquat Intoxication Who Survived the Initial Injury | 2006 | 1 |
About Chin‐Chan Lee
Chin‐Chan Lee is a scholar working on Nephrology, Complementary and Manual Therapy and Transplantation, having authored 65 papers that have together received 1.2k indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (27 papers), Chronic Kidney Disease and Diabetes (12 papers), Retinal Imaging and Analysis (6 papers), Retinal Diseases and Treatments (5 papers), Diet and metabolism studies (4 papers), Effects and risks of endocrine disrupting chemicals (4 papers), Restless Legs Syndrome Research (4 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Nephrology (576 citations), Emergency Medical Services (86 citations) and Biological Psychiatry (20 citations). Chin‐Chan Lee has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Chiao‐Yin Sun, I‐Wen Wu, Heng-Jung Hsu, Mai-Szu Wu, Chia‐Chi Chou, Liang‐Jen Wang, Chun‐Yu Chen, Heng‐Chih Pan, Chi‐Ren Tsai and Chih‐Ken Chen. Their work appears in journals such as PLoS ONE, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.